Cargando…

APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance

BACKGROUND: Virtually few accurate and robust prediction models of lower-grade gliomas (LGG) survival exist that may aid physicians in making clinical decisions. We aimed to develop a prognostic prediction model of LGG by incorporating demographic, clinical and transcriptional biomarkers with either...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiajin, Shen, Sipeng, Li, Yi, Fan, Juanjuan, Xiong, Shiyu, Xu, Jingtong, Zhu, Chenxu, Lin, Lijuan, Dong, Xuesi, Duan, Weiwei, Zhao, Yang, Qian, Xu, Liu, Zhonghua, Wei, Yongyue, Christiani, David C., Zhang, Ruyang, Chen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035655/
https://www.ncbi.nlm.nih.gov/pubmed/35436725
http://dx.doi.org/10.1016/j.ebiom.2022.104007
_version_ 1784693343358287872
author Chen, Jiajin
Shen, Sipeng
Li, Yi
Fan, Juanjuan
Xiong, Shiyu
Xu, Jingtong
Zhu, Chenxu
Lin, Lijuan
Dong, Xuesi
Duan, Weiwei
Zhao, Yang
Qian, Xu
Liu, Zhonghua
Wei, Yongyue
Christiani, David C.
Zhang, Ruyang
Chen, Feng
author_facet Chen, Jiajin
Shen, Sipeng
Li, Yi
Fan, Juanjuan
Xiong, Shiyu
Xu, Jingtong
Zhu, Chenxu
Lin, Lijuan
Dong, Xuesi
Duan, Weiwei
Zhao, Yang
Qian, Xu
Liu, Zhonghua
Wei, Yongyue
Christiani, David C.
Zhang, Ruyang
Chen, Feng
author_sort Chen, Jiajin
collection PubMed
description BACKGROUND: Virtually few accurate and robust prediction models of lower-grade gliomas (LGG) survival exist that may aid physicians in making clinical decisions. We aimed to develop a prognostic prediction model of LGG by incorporating demographic, clinical and transcriptional biomarkers with either main effects or gene-gene interactions. METHODS: Based on gene expression profiles of 1,420 LGG patients from six independent cohorts comprising both European and Asian populations, we proposed a 3-D analysis strategy to develop and validate an Accurate Prediction mOdel of Lower-grade gLiomas Overall survival (APOLLO). We further conducted decision curve analysis to assess the net benefit (NB) of identifying true positives and the net reduction (NR) of unnecessary interventions. Finally, we compared the performance of APOLLO and the existing prediction models by the first systematic review. FINDINGS: APOLLO possessed an excellent discriminative ability to identify patients at high mortality risk. Compared to those with less than the 20(th) percentile of APOLLO risk score, patients with more than the 90(th) percentile of APOLLO risk score had significantly worse overall survival (HR=54·18, 95% CI: 34·73-84·52, P=2·66 × 10(−69)). Further, APOLLO can accurately predict both 36- and 60-month survival in six independent cohorts with a pooled AUC(36-month)=0·901 (95% CI: 0·879-0·923), AUC(60-month)=0·843 (95% CI: 0·815-0·871) and C-index=0·818 (95% CI: 0·800-0·835). Moreover, APOLLO offered an effective screening strategy for detecting LGG patients susceptible to death (NB(36-month)=0·166, NR(36-month)=40·1% and NB(60-month)=0·258, NR(60-month)=19·2%). The systematic comparisons revealed APOLLO outperformed the existing models in accuracy and robustness. INTERPRETATION: APOLLO has the demonstrated feasibility and utility of predicting LGG survival (http://bigdata.njmu.edu.cn/APOLLO). FUNDING: National Key Research and Development Program of China (2016YFE0204900); Natural Science Foundation of Jiangsu Province (BK20191354); National Natural Science Foundation of China (81973142 and 82103946); China Postdoctoral Science Foundation (2020M681671); National Institutes of Health (CA209414, CA249096, CA092824 and ES000002).
format Online
Article
Text
id pubmed-9035655
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90356552022-04-26 APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance Chen, Jiajin Shen, Sipeng Li, Yi Fan, Juanjuan Xiong, Shiyu Xu, Jingtong Zhu, Chenxu Lin, Lijuan Dong, Xuesi Duan, Weiwei Zhao, Yang Qian, Xu Liu, Zhonghua Wei, Yongyue Christiani, David C. Zhang, Ruyang Chen, Feng EBioMedicine Articles BACKGROUND: Virtually few accurate and robust prediction models of lower-grade gliomas (LGG) survival exist that may aid physicians in making clinical decisions. We aimed to develop a prognostic prediction model of LGG by incorporating demographic, clinical and transcriptional biomarkers with either main effects or gene-gene interactions. METHODS: Based on gene expression profiles of 1,420 LGG patients from six independent cohorts comprising both European and Asian populations, we proposed a 3-D analysis strategy to develop and validate an Accurate Prediction mOdel of Lower-grade gLiomas Overall survival (APOLLO). We further conducted decision curve analysis to assess the net benefit (NB) of identifying true positives and the net reduction (NR) of unnecessary interventions. Finally, we compared the performance of APOLLO and the existing prediction models by the first systematic review. FINDINGS: APOLLO possessed an excellent discriminative ability to identify patients at high mortality risk. Compared to those with less than the 20(th) percentile of APOLLO risk score, patients with more than the 90(th) percentile of APOLLO risk score had significantly worse overall survival (HR=54·18, 95% CI: 34·73-84·52, P=2·66 × 10(−69)). Further, APOLLO can accurately predict both 36- and 60-month survival in six independent cohorts with a pooled AUC(36-month)=0·901 (95% CI: 0·879-0·923), AUC(60-month)=0·843 (95% CI: 0·815-0·871) and C-index=0·818 (95% CI: 0·800-0·835). Moreover, APOLLO offered an effective screening strategy for detecting LGG patients susceptible to death (NB(36-month)=0·166, NR(36-month)=40·1% and NB(60-month)=0·258, NR(60-month)=19·2%). The systematic comparisons revealed APOLLO outperformed the existing models in accuracy and robustness. INTERPRETATION: APOLLO has the demonstrated feasibility and utility of predicting LGG survival (http://bigdata.njmu.edu.cn/APOLLO). FUNDING: National Key Research and Development Program of China (2016YFE0204900); Natural Science Foundation of Jiangsu Province (BK20191354); National Natural Science Foundation of China (81973142 and 82103946); China Postdoctoral Science Foundation (2020M681671); National Institutes of Health (CA209414, CA249096, CA092824 and ES000002). Elsevier 2022-04-15 /pmc/articles/PMC9035655/ /pubmed/35436725 http://dx.doi.org/10.1016/j.ebiom.2022.104007 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Chen, Jiajin
Shen, Sipeng
Li, Yi
Fan, Juanjuan
Xiong, Shiyu
Xu, Jingtong
Zhu, Chenxu
Lin, Lijuan
Dong, Xuesi
Duan, Weiwei
Zhao, Yang
Qian, Xu
Liu, Zhonghua
Wei, Yongyue
Christiani, David C.
Zhang, Ruyang
Chen, Feng
APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
title APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
title_full APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
title_fullStr APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
title_full_unstemmed APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
title_short APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
title_sort apollo: an accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035655/
https://www.ncbi.nlm.nih.gov/pubmed/35436725
http://dx.doi.org/10.1016/j.ebiom.2022.104007
work_keys_str_mv AT chenjiajin apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT shensipeng apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT liyi apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT fanjuanjuan apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT xiongshiyu apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT xujingtong apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT zhuchenxu apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT linlijuan apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT dongxuesi apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT duanweiwei apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT zhaoyang apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT qianxu apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT liuzhonghua apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT weiyongyue apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT christianidavidc apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT zhangruyang apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance
AT chenfeng apolloanaccurateandindependentlyvalidatedpredictionmodeloflowergradegliomasoverallsurvivalandacomparativestudyofmodelperformance